On February 1, 2017, the final participant completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado led by Principal Investigator Marcela Ot’alora, M.A., L.P.C. All treatment sessions and long-term follow-up interviews for this study have now been completed. These data will provide additional information to guide the design of our upcoming Phase 3 trials. The final results are being prepared for publication, which is expected in 2017. Learn more…
